These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 15611723

  • 1. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ, Wacker JL.
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [Abstract] [Full Text] [Related]

  • 2. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK, Paul S.
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polyglutamine diseases and molecular chaperones.
    Kimura Y, Kakizuka A.
    IUBMB Life; 2003 Jun; 55(6):337-45. PubMed ID: 12938736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A, Janig E, Stumptner C, Fuchsbichler A, Zatloukal K, Denk H.
    Pathobiology; 2007 Jun; 74(3):145-58. PubMed ID: 17643060
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF, Tetzlaff J.
    Semin Pediatr Neurol; 2007 Mar; 14(1):15-25. PubMed ID: 17331880
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
    Nakamura T, Lipton SA.
    Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
    [Abstract] [Full Text] [Related]

  • 13. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB, Sherman MY.
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [Abstract] [Full Text] [Related]

  • 14. Protein misfolding and neurodegeneration.
    Soto C, Estrada LD.
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [Abstract] [Full Text] [Related]

  • 15. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM, Fischer DF, Ovaa H, Scheper W.
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [Abstract] [Full Text] [Related]

  • 16. Quality control against misfolded proteins in the cytosol: a network for cell survival.
    Kubota H.
    J Biochem; 2009 Nov; 146(5):609-16. PubMed ID: 19737776
    [Abstract] [Full Text] [Related]

  • 17. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
    Kim YJ, Takahashi R.
    Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
    [Abstract] [Full Text] [Related]

  • 18. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
    Hachiya NS, Kozuka Y, Kaneko K.
    Med Hypotheses; 2008 Nov; 70(5):1034-7. PubMed ID: 17910993
    [Abstract] [Full Text] [Related]

  • 19. Free radicals and low-level photon emission in human pathogenesis: state of the art.
    Van Wijk R, Van Wijk EP, Wiegant FA, Ives J.
    Indian J Exp Biol; 2008 May; 46(5):273-309. PubMed ID: 18697612
    [Abstract] [Full Text] [Related]

  • 20. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
    Muchowski PJ.
    Neuron; 2002 Jul 03; 35(1):9-12. PubMed ID: 12123602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.